Evidence map›Paper›PMID 33251989›Full record

ArticleJournal of managed care & specialty pharmacy2020

Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.

David R Axon, Shannon Vaffis, Chanadda Chinthammit, Breanne E Lott, Ann M Taylor, Matthew Pickering, Heather Black, Terri Warholak, Patrick J Campbell

Open access · bronzeAbstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Zero Dollar Copay Pharmacy Benefit Decreases Healthcare Expenditures Among Members With Type 2 Diabetes of Blue Cross Blue Shield of Louisiana.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024
    Review
  9. Article
  10. Article
  11. An Analysis of Medication Adherence in a Large Outpatient Population During the COVID-19 Pandemic Using a Novel Value-Based Pharmacy System.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2024
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

David R AxonUniversity of Arizona College of Pharmacy, Tucson.
Shannon VaffisUniversity of Arizona College of Pharmacy, Tucson.
Chanadda ChinthammitUniversity of Arizona College of Pharmacy, Tucson, and Eli Lilly and Company, Indianapolis, IN.
Breanne E LottMel & Enid Zuckerman College of Public Health, University of Arizona, Tucson.
Ann M TaylorUniversity of Arizona College of Pharmacy, Tucson.
Matthew PickeringPharmacy Quality Alliance, Alexandria, VA.
Heather BlackMerck & Co., Kenilworth, NJ.
Terri WarholakUniversity of Arizona College of Pharmacy, Tucson.
Patrick J CampbellUniversity of Arizona College of Pharmacy, Tucson, and Pharmacy Quality Alliance, Alexandria, VA .
University of Arizona · USMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug MonitoringQuality Indicators, Health CareAgedCohort StudiesDatabases, FactualFemaleHealth Care CostsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMedicarePatient Acceptance of Health CareRetrospective StudiesUnited StatesHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID33251989
PMCPMC10390988
OpenAlexW3108978686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.